Table 3 Post-coronary heart disease event exposure of cardiovascular medications by CKD status.*
Medication Class | CKD (N = 159) Medication Possession Ratio (SD) | Non-CKD (N = 1088) Medication Possession Ratio (SD) | P Value |
|---|---|---|---|
Statin | 0.82 (0.25) N = 155 | 0.79 (0.27) N = 1034 | 0.3 |
β-blockers | 0.78 (0.30) N = 146 | 0.74 (0.3) N = 1026 | 0.2 |
Calcium channel blockers | 0.47 (0.38) N = 80 | 0.39 (0.37) N = 350 | 0.06 |
Angiotensin converting enzyme inhibitors | 0.50 (0.39) N = 137 | 0.58 (0.38) N = 874 | 0.03 |
Angiotensin receptor blockers | 0.50 (0.35) N = 36 | 0.52 (0.34) N = 203 | 0.8 |